in silico methods in fragment-based drug design — a Protein Kinase B case study

webinar

Wed, 28 Jan 2015, 19:00 CET (Berlin)

Dr. Alastair Donald, BioSolveIT GmbH, St. Augustin, Germany

in silico methods in fragment-based drug design — a Protein Kinase B case study

Computational tools are invaluable in the process of identifying high-quality fragment hits. In this one hour BioSolveIT webinar you will learn how to fast-track your fragment hit discovery using our cutting edge in silico solutions using Protein Kinase B as an example.

By the end you will appreciate how our suite of SBDD tools can enrich your work life, enhance your productivity and assist in the identification of potent, selective and synthetically accessible lead-like molecules.

So, if you are interested in

  • enriching your screening collection with potent and selective fragments
  • intelligently selecting which commercially available analogs to purchase
  • deciding which analogs to prioritize for synthesis
  • saving time and money by focusing on the most promising ideas

watch the video live recording below.

Current news

category
Events
Recordings of the BioSolveIT Day 2025 Available
October 15, 2025 13:39 CEST
Missed BioSolveIT Day 2025? The recordings from BioSolveIT Day 2025 are now live! Packed with practical insights for medicinal and computational chemists, the sessions showcase how SeeSAR, infiniSee, Chemical Space Docking®, and CoLibri accelerate real-world discovery, from pocket-aware design and HYDE-guided decisions to trillion-scale, synthesizable chemical space exploration and in-house...
Read on
Enamine’s REAL Space September 2025 Update - Now 83 Billion!
September 23, 2025 10:31 CEST
The September 2025 update of Enamine’s REAL Space brings a new expansion, now featuring over 83 billion accessible, drug-like products, up from 76 billion in the previous release. Built from 172 curated reactions and 192,487 reagents and building blocks based on in-house knowledge, this version further enhances one of the...
Read on
WuXi’s GalaXi Space September 2025 – Expanded to 26 Billion Molecules!
September 17, 2025 10:03 CEST
The September 2025 update of WuXi LabNetwork’s GalaXi Space delivers a major expansion, now featuring over 25.8 billion synthesis-ready products. Built from 185 curated reactions and 30,877 high-quality building blocks, GalaXi is one of the largest tangible Chemical Spaces for modern drug discovery. This release broadens structural diversity with novel...
Read on